Archer Materials Limited · ASX:AXE
Archer Materials — Investor Presentation (January 2026)
10 slides from Archer Materials's investor presentation, Jan 29, 2026
Slide 1: Investor Webinar - Presentation (ASX Announcement)
Archer Materials Archer Materials Limited (ACN: 123 993 233) Corporate Lot Fourteen, Frome Road, Adelaide SA 5000 www.archerx.com.au ASX Announcement (ASX: AXE) 29 January 2026 Investor Webinar - Presentation Archer Materials Limited (“Archer”, the “Company”, “ASX: AXE”) is pleased to enclose a copy
Slide 2: Q2 FY26 update
For personal use only Q2 FY26 update Simon Ruffell, Chief Executive Officer 29 January 2026
Slide 3: Archer at a glance
‣ Technology roadmap of quantum IP in Archer at a glance medical, sensing, and computing. For personal use only Archer Materials (ASX: AXE) is the only ASX-listed quantum ‣ Headquarters in Australia technology company. We are developing IP for use in quantum computing, sensing and medical diagnostic
Slide 4: Significant advantages of Archer's quantum chip
Designed for scalability Significant Built with materials and processes that can scale using today’s semiconductor fabrication methods and integrated with today’s chips. advantages For personal use only Improved control of Archer’s Archer’s chip will have improved control capabilities and stability,
Slide 5: Quantum sensing for next-gen deep tech applications
Quantum Quantum sensing for next- Developing quantum sensors with exceptional precision for advanced gen deep tech applications For personal use only markets in AI hardware, data centres, IoT, autonomous vehicles, medicine, and more. Quantum sensing underpins Collaborating with industry and Built on
Slide 6: Biochip: A Sensing Platform
BIOCHIP A Sensing Platform Beyond this beachhead application, the platform will address a range of other markets. For personal use only Archer is developing a world-first biosensor to measure blood potassium levels from a simple finger-prick sample, allowing for regular point-of-care and at-home Bui
Slide 7: Q2 FY26 Highlights
Q2 FY26 Highlights Delivered technical milestones, positioning Archer for key product demonstrations in 2026 For personal use only Quantum computing & sensing Biochip Corporate ‣ Improved quantum state readout for ‣ Demonstrated that the graphene-based ‣ Receipt of an R&D tax rebate from the carbon
Slide 8: Commercial roadmap
Commercial roadmap Archer’s three programs follow parallel paths from proof-of-concept to product demonstration and commercial partnerships. For personal use only Technology 2025 2026 2027 2028+ Quantum computing Achieved key qubit Qubit demonstration Scale-up of quantum Licensing arrangements of mi
Slide 9: 2026 Key Milestones
2026 Key Milestones ‣ Lab demonstrator/alpha prototype of blood potassium early 2026. For personal use only Calendar years to 2027 ‣ Blood potassium prototype sensor in 2026 for use in trials Early demo of next gen biochip Biochip lab Biochip prototype ‣ End of 2026 begin clinical trials for blood B
Slide 10: Thank you
Thank you For personal use only ASX Code: AXE Subscribe to The Executive Chair of Archer Sydney Adelaide Materials authorised this Level 2, 477 Pitt St Lot Fourteen, Frome Rd our newsletter announcement to be given to the ASX. Sydney NSW 2000 Adelaide SA 5000 Archer Materials Limited ABN 64 123 993
Archer Materials — Investor Presentation (January 2026) on 6ix